Abiopharma

Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists

Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference

Ruanyun Edai Technology Secures $1.73 Million Strategic Financing to Accelerate Global Expansion and Transition of Its New Identity Formind Group

CISO Global Files No-Action Request with SEC Seeking Investor-Consent Framework for Securities Lending

GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions

Popular Inc. Announces Executive Leadership Changes

Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares

Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

Waystar to Announce First Quarter 2026 Financial Results on April 29, 2026

BTCS to Participate in Water Tower Research Insights Conference on April 14, 2026